Bathi saben saham sajrone rolas wulan pungkasan: Personalis Inc (PSNL)
Genomic sequencing costs and the implementation of MRD tests are creating financial pressure, as evidenced by the 12-month earnings per share history, where the current level sits around -1.17. Personalis, Inc. (PSNL) can achieve optimization through its NeXt Personal AI platform for early screening and its status as a recognized scientific leader in high-sensitivity analysis, which strengthens the trust of major medical centers.
Rincian analitis lan laporan data perusahaan Personalis Genomics (PSNL)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Personalis, Inc.|PSNL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Personalis, Inc.|PSNL - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Personalis|PSNL - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Personalis|Likuiditas cepet personalis.com
- indikator pendapatan resik lan kelipatan nilai:
PSNL - Bathi perusahaan|Proyeksi bathi mangsa ngarep Personalis, Inc.|PSNL - Pangali P/E|Rega marang bathi mangsa ngarep Personalis Corp|PSNL - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Personalis|PSNL - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Personalis|PSNL - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan personalis.com|PSNL - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Personalis, Inc.
- data pendapatan lan penerimaan dodolan:
Analisis umum perusahaan:PSNL - Personalis Inc
Personalis, Inc. (PSNL) monetization of genetic data arrays through contracts with pharma giants directly impacts the business's bottom-line profitability, reflecting the efficiency of converting intellectual capital into actual revenue. This metric is calculated as the ratio of net income to the number of shares, and analyzing the rolling annual net income per share on GURU.Markets allows for the timely identification of trend degradation to ensure prompt portfolio rebalancing.
Pesaing Personalis, Inc.
ONC - Bathi saben saham sajrone rolas wulan pungkasan|HALO - Bathi resik saben saham (EPS TTM)|RevMed (RVMD) - Bathi saben saham sajrone rolas wulan pungkasan|Ascentage - Bathi saben saham sajroning taun lumaku|CGON (CG Oncology Inc) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan UroGen Pharma URGN|Bathi resik saben saham (EPS TTM) BCAX|ERAS - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi resik saben saham (EPS TTM) DCTH (delcath.com)|Bathi resik saben saham sajroning taun lumaku Y-mAbs Corp|AURA - Bathi saben saham sajrone rolas wulan pungkasan|CADL (candeltx.com) - Bathi saben saham sajrone 12 wulan pungkasan|ARAY (accuray.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|SELLAS Life Sciences Group Inc. (SLS) - Bathi resik saben saham (EPS TTM)|ACTU (Actuate Therapeutics Inc.) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Citius Oncology Inc|Bathi resik saben saham (EPS TTM) HURA|TARA (Protara Therapeutics) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) FATE (Fate Therapeutics)|Bathi resik saben saham sajrone patang kuartal pungkasan Aadi Bioscience Inc (WHWK)|TScan Therapeutics, Inc. - Bathi resik saben saham (EPS TTM)|CSBR (Champions Oncology, Inc.) - Bathi saben saham sajrone 12 wulan pungkasan|XBIT (XBiotech USA) - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan CEL-SCI Corp (CVM)|OSTX (OS Therapies Inc.) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan Radiopharm Theranostics (RADX)|Bathi resik saben saham sajrone 12 wulan pungkasan ARTV (Artiva Biotherapeutics, Inc.)|ANL - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Veru Inc. VERU|Bathi saben saham sajroning taun lumaku TPST|XLO: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham sajrone patang kuartal pungkasan Renovaro RENB|MURA (muraloncology.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|Kairos Pharma Inc - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham sajrone 12 wulan pungkasan OKUR|Bathi resik saben siji saham sajrone rolas wulan pungkasan CytoMed Therapeutics Limited GDTC|Bathi resik saben saham (EPS TTM) CRIS|Bathi resik saben saham (EPS TTM) Apollomics Inc. (APLM)|Bathi resik saben saham (EPS TTM) THAR (Tharimmune Corp)|Bathi resik saben saham sajrone patang kuartal pungkasan Advanced Biomed Inc (ADVB)|Genprex Inc - Bathi resik saben saham (EPS TTM)|CLDI - Bathi resik saben saham (EPS TTM)|Sunshine Biopharma Inc. (SBFM) - Bathi saben saham sajrone rolas wulan pungkasan|XBIO - Bathi resik saben saham sajrone patang kuartal pungkasan|SLRX (Salarius Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Kitov Pharma|Bathi resik saben saham sajrone 12 wulan pungkasan AONC (American Oncology Network)|BGNE - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi resik saben saham (EPS TTM) CKPT (Checkpoint Therapeutics Inc.)|Elevation Oncology, Inc. - Bathi saben saham sajrone rolas wulan pungkasan|ICAD - Bathi saben saham sajrone rolas wulan pungkasan|IKNA - Bathi resik saben saham (EPS TTM)|Notable Labs (NTBL) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone 12 wulan pungkasan VIRX|MOR (MorphoSys Corporation) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan NAYA Biosciences Inc NAYA|Bathi saben saham sajrone rolas wulan pungkasan Ascentage Pharma (AAPGV)
